Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation

Stem Cells

Volumn 14, Issue SUPPL. 1, 1996, Pages 124-132

  Alexander, Warren S ^a   Roberts, Andrew W ^a   Maurer, Alexander B ^a   Nicola, Nicos A ^a   Dunn, Ashley R ^a   Metcalf, Donald ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

c Mpl; Gene targeting; Hemopoietin receptor; Megakaryocytopoiesis; Thrombopoietin

Indexed keywords

COMPLEMENTARY DNA; CYSTEINE; CYTOKINE RECEPTOR; LIGAND; MPL PROTEIN, HUMAN; ONCOPROTEIN; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; TUMOR PROTEIN;

ANIMAL; BIOLOGICAL MODEL; BONE MARROW CELL; CHEMISTRY; DIMERIZATION; GENE EXPRESSION REGULATION; GENETIC RECOMBINATION; GENETICS; HEMATOPOIETIC STEM CELL; HOMOZYGOTE; LIVER; MEGAKARYOCYTE; METABOLISM; MOUSE; MOUSE MUTANT; MUTAGENESIS; PHENOTYPE; PHOSPHORYLATION; PHYSIOLOGY; PRENATAL DEVELOPMENT; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA;

ANIMALS; BONE MARROW CELLS; CYSTEINE; DIMERIZATION; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HOMOZYGOTE; LIGANDS; LIVER; MEGAKARYOCYTES; MICE; MICE, KNOCKOUT; MODELS, GENETIC; MUTAGENESIS; NEOPLASM PROTEINS; PHENOTYPE; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; RECOMBINATION, GENETIC; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 0030307545     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530140716     Document Type: Article

References (44)

1. Gearing DP, King JA, Gough NM et al. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J 1989;8:3667-3676.
2. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990;87:6934-6938.
3. O'Neal KD, Yu-Lee L-Y. The proline-rich motif (PRM): a novel feature of the cytokine/hematopoietin receptor superfamily. Lymphokine Cytokine Res 1993;12:309-312.
4. Souyri M, Vigon I, Pencioelli J-F et al. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990;63:1137-1147.
5. Wendling F, Varlet P, Charon M et al. MPLV: a retrovirus complex inducing an acute myeloproliferative disorder in adult mice. Virology 1986;149:242-246.
6. Wendung F, Vigon I, Souyri M et al. Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without the addition of growth factors. Leukemia 1989;3:475-480.
7. Vigon I, Mornon J-P, Cocault L et al. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 1992;89:5640-5644.
8. Methia N, Louache F, Vainchenker W et al. Oligodeoxynucleotides antisense to the protooncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993;82:1395-1401.
9. Alexander WS, Dunn AR. Structure and transcription of the genomic locus encoding murine c-Mpl, a receptor for thrombopoietin. Oncogene 1995;10:795-803.
10. Keleman E, Cserhati I, Tanos B. Demonstration and some properties of thrombopoietin in thrombocythemic sera. Acta Haematol (Basel) 1958;20:350-355.
11. Bartley TD, Bogenberger J, Hunt P et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-1124.
12. de Sauvage FJ, Hass PE, Spencer SD et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
13. Lok S, Kaushansky K, Holly RD et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-568.
14. Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995;85:1719-1726.
15. Hunt P, Li Y-S, Nichol JL et al. Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood 1995;86:540-547.
16. Banu N, Wang JF, Deng B et al. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. Blood 1995;86:1331-1338.
17. Kaushansky K, Lok S, Holly RD et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994;369:568-571.
18. Debili N, Wendung F, Katz A et al. The Mpl ligand or thrombopoietin or megakaryocyte growth and differentiation factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995;86:2516-2525.
19. Ulich TR, del Castillo J, Yin S et al. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995;86:971-976.
20. Farese AM, Hunt P, Boone T et al. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 1995;86:54-59.
21. Alexander WS, Metcalf D, Dunn AR. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J 1995;14:5569-5578.
22. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994;76:253-262.
23. Nicola NA, Metcalf D. Subunit promiscuity among hemopoietic growth factor receptors. Cell 1991;67:1-4.
24. 2 rat lymphoma cells. J Biol Chem 1990;265:14770-14776.
25. Fukunaga R, Ishizaka-Ikeda E, Nagata S. Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J Biol Chem 1990;265:14008-14015.
26. Cunningham BC, Ultsch M, deVos AM et al. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 1991;254:821-825.
27. Fuh G, Cunningham BC, Fukunaga R et al. Rational design of potent antagonists to the human growth hormone receptor. Science 1992;256:1677-1680.
28. Hooper KP, Padmanabhan R, Ebner KE. Expression of the extracellular domain of the rat liver prolactin receptor and its interaction with ovine prolactin. J Biol Chem 1993;268:22347-22352.
29. Yoshimura A, Longmore G, Lodish HF. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 1990;348:647-649.
30. Watowich SS, Yoshimura A, Longmore GD et al. Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci USA 1992;89:2140-2144.
31. Watowich SS, Hilton DJ, Lodish HF. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol Cell Biol 1994;14:3535-3549.
32. de Vos AM, Ultsh M, Kossiakoff AA. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992;255:306-312.
33. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques 1989;7:980-990.
34. Vigon I, Dreyfus F, Melle J et al. Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood 1993;82:877-883.
35. Ihle JN, Kerr IM. Jaks and STATs in signaling by the cytokine receptor superfamily. TIGS 1995;11:69-74.
36. Drachman JG, Griffin JD, Kaushansky K. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, She and c-Mpl. J Biol Chem 1995;270:4979-4982.
37. Gurney AL, Wong SC, Henzel WJ et al. Distinct regions of the c-Mpl cytoplasmic domain are coupled to the Jak-STAT signal transduction pathway and Shc phosphorylation. Proc Natl Acad Sci USA 1995;92:5292-5296.
38. Duquesnoy P, Sobrier M-L, Duriez B et al. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J 1994;13:1386-1395.
39. Alexander WS, Roberts AW, Nicola NA et al. Deficiencies in progenitor cells of multiple hemopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 1996;87:2162-2170.
40. Szabo P, Mann JR. Expression and methylation of imprinted genes during in vitro differentiation of mouse parthenogenetic and androgenetic embryonic stem cell lines. Development 1994;120:1651-1660.
41. Gurney AL, Carver-Moore K, de Sauvage FJ et al. Thrombocytopenia in c-mpl-deficient mice. Science 1994;265:1445-1447.
42. Choi ES, Hokom M, Bartley T et al. Recombinant human megakaryocyte growth and development factor (MGDF), a ligand for c-Mpl, produces functional human platelets in vitro. STEM CELLS 1995;13:317-322.
43. Debili N, Wendling F, Cosman D et al. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995;85:391-401.
44. Zeigler FC, de Sauvage F, Widmer HR et al. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994;84:4045-4052.